Page 27 - Service Testing News Today

The drugmaker says the trial demonstrated a statistically significant and clinically meaningful improvement for the primary endpoint of progression-free...

By Dean Seal Shares of Lixte Biotechnologies jumped after the company said it will launch a trial to assess whether its drug LB-100 can aid immunotherapy in...

By Colin Kellaher Seelos Therapeutics shares tumbled in premarket trading Wednesday after the clinical-stage biopharmaceutical company said a Phase 2 study...

By Denny Jacob Aquestive Therapeutics shares rose 12% to $1.72 on news it expects to continue starting its clinical trial of oral epinephrine product...

By Joe Hoppe Avacta Group shares rose after it said it successfully completed a sixth dose escalation in its AVA6000 tumor treatment study, and now plans to...

By Sabela Ojea Shares of Scholar Rock on Tuesday climbed after the company said it has completed the enrollment for the phase 3 trial of a drug that targets...

By Ben Glickman Rocket Pharmaceuticals said on Tuesday that it had reached alignment with the U.S. Food and Drug Administration on a trial for its treatment...

Rocket Pharmaceuticals reaches alignment with the Food and Drug Administration regarding its global Phase 2 trial for a treatment of Danon disease.

Moderna expects to launch up to 15 new products over the next five years 'addressing high unmet needs.'

As COVID vaccine sales fall, Moderna releases positive results from mRNA flu vaccine, adds new development programs